Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
Medivolve Inc.February 19, 2021 GMT
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the cancellation of the agreement to acquire 100% of Karland Health, LLC. As noted in the initial press release dated February 11th, 2021, the completion of the transaction to acquire Karland Health was subject to customary closing conditions, including due diligence to the satisfaction of Medivolve. After completing further due diligence, management determined that the acquisition of Karland Health would not be sufficiently accretive for the Company.
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Medivolve Also Strengthens its Balance Sheet via Shares for Debt SettlementsTORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that it has signed a binding letter of intent to acquire 100% of Karland Health, LLC. In 2020, Medivolve’s wholly owned subsidiary, Collection Sites LLC, launched COVID-19 testing services in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, California. Collection Sites opened their first testing location on August 8, 2020 and has grown substantially since with January tests conducted of 73,973 at an average price of US$96 per test. Appointments and payments are handled through an online portal www.testbeforeyougo.com. Under the terms set out in the agreement, Medivolve is to issue a total of 20 million Medivolve common shares to the shareholders of Karland Health in e
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Enters into Agreement to Acquire Karland Health, Enabling its Wholly Owned .
Medivolve Inc.February 11, 2021 GMT
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that it has signed a binding letter of intent to acquire 100% of Karland Health, LLC. In 2020, Medivolve’s wholly owned subsidiary, Collection Sites LLC, launched COVID-19 testing services in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, California. Collection Sites opened their first testing location on August 8, 2020 and has grown substantially since with January tests conducted of 73,973 at an average price of US$96 per test. Appointments and payments are handled through an online portal www.testbeforeyougo.com.